Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone 
Samsung Reports Record Profit as AI Boom Drives Memory Chip Demand 
Microsoft Azure Growth Forecast Beats Expectations Amid Rising AI Competition 
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook 
Standard Chartered Q1 Profit Hits Record on Wealth and Investment Banking Growth 
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales 
Berkshire Hathaway Meeting Sees Shift as Greg Abel Steps Into Leadership Spotlight 
Spirit Airlines Shuts Down Flights, Issues Refunds After Financial Collapse 
U.S. Cybersecurity Pushes Faster Patch Deadlines Amid Rising AI-Driven Threats 
Alphabet Earnings Surge on AI Growth, Cloud Revenue, and Strong Search Performance 
GameStop Proposes $56 Billion eBay Acquisition in Bold Strategic Move 
United Airlines Flight Hits Light Pole During Newark Landing, FAA Investigates 
Middle East Conflict Impacts Australia and New Zealand Businesses 
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth 
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List 
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement 
Coles Group Q3 Sales Rise Driven by Supermarkets and E-Commerce Growth 
BURLINGTON, Mass., May 03, 2018 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be presenting in three conferences in May.
David Roberts, President, is scheduled to present at the Deutsche Bank Healthcare Conference on Tuesday, May 8, 2018 at the InterContinental Hotel in Boston, MA. The Company’s presentation is scheduled to begin at 10:40 AM EDT.
George LeMaitre, Chairman & CEO, is scheduled to present at the East Coast IDEAS Conference on Wednesday, May 9, 2018 at the Boston Park Plaza Hotel in Boston, MA. The Company’s presentation is scheduled to begin at 11:10 AM EDT.
David Roberts, President, is scheduled to present at the UBS Healthcare Conference on Tuesday, May 22, 2018 at the Grand Hyatt New York Hotel in New York City. The Company’s presentation is scheduled to begin at 3:30 PM EDT.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
Contact: LeMaitre Vascular, Inc.
Investor Relations
Steven Chehames
+1-781-425-1659
[email protected]
